Kim-hien Dao
Physician · Oregon Specialty Group
Credentials: · · · ·
History
- 2021–Present
- 2006–2007
Hematology
- 2003–2006
Internal Medicine
Research
Functional genomic landscape of acute myeloid leukaemia
Nature · 2018 · 1,111 citations
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia
Cancer Cell · 2022 · 343 citations
Journal of Clinical Oncology · 2020 · First of 26 authors · 91 citations
4 papers
4 papers
3 papers · 1 as a resident
3 papers
3 papers
3 papers
- AD
2 papers
2 papers · 1 as a resident
Grants
- 2018–2020
Immune Checkpoint Abnormalities in Human Subjects with Clonal Hematopoiesis
National Heart, Lung, and Blood Institute · R03
Contact PI · $154K · Oregon Health & Science University
- 2017–2019
Defining Monocyte Abnormalities Caused by Age-Associated Mutations in Epigenetic Regulatory Genes
National Institute on Aging · R21
Contact PI · $423.5K · Oregon Health & Science University
- 2012–2017
Beta-Catenin Is a Molecular Target of the Fanconi Anemia Core Complex
National Heart, Lung, and Blood Institute · K08
Contact PI · $670.7K · Oregon Health & Science University
Clinical trials
- 2014–2020
Principal investigator · Completed · Phase 2
OHSU Knight Cancer Institute